235 related articles for article (PubMed ID: 38350915)
21. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T
J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443
[TBL] [Abstract][Full Text] [Related]
22. Proteomic approach to profiling immune complex antigens in cerebrospinal fluid samples from patients with central nervous system autoimmune diseases.
Aibara N; Ichinose K; Baba M; Nakajima H; Satoh K; Atarashi R; Kishikawa N; Nishida N; Kawakami A; Kuroda N; Ohyama K
Clin Chim Acta; 2018 Sep; 484():26-31. PubMed ID: 29775619
[TBL] [Abstract][Full Text] [Related]
23. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
[TBL] [Abstract][Full Text] [Related]
24. Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.
Barschke P; Oeckl P; Steinacker P; Ludolph A; Otto M
Expert Rev Proteomics; 2017 Sep; 14(9):769-777. PubMed ID: 28799854
[TBL] [Abstract][Full Text] [Related]
25. Proteomics analysis of human cerebrospinal fluid.
Yuan X; Desiderio DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
[TBL] [Abstract][Full Text] [Related]
26. Characterization of individual mouse cerebrospinal fluid proteomes.
Smith JS; Angel TE; Chavkin C; Orton DJ; Moore RJ; Smith RD
Proteomics; 2014 May; 14(9):1102-6. PubMed ID: 24677814
[TBL] [Abstract][Full Text] [Related]
27. A comparative proteomic analysis of human and rat embryonic cerebrospinal fluid.
Zappaterra MD; Lisgo SN; Lindsay S; Gygi SP; Walsh CA; Ballif BA
J Proteome Res; 2007 Sep; 6(9):3537-48. PubMed ID: 17696520
[TBL] [Abstract][Full Text] [Related]
28. Rapidly maturing field of proteomics: a gateway to studying diseases.
Schutzer SE
Proteomics; 2014 May; 14(9):991-3. PubMed ID: 24668871
[TBL] [Abstract][Full Text] [Related]
29. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid.
Yuan X; Desiderio DM
Proteomics; 2005 Feb; 5(2):541-50. PubMed ID: 15627968
[TBL] [Abstract][Full Text] [Related]
30. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
[TBL] [Abstract][Full Text] [Related]
31. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Cerebrospinal Fluid via Data-Independent Acquisition Mass Spectrometry.
Barkovits K; Linden A; Galozzi S; Schilde L; Pacharra S; Mollenhauer B; Stoepel N; Steinbach S; May C; Uszkoreit J; Eisenacher M; Marcus K
J Proteome Res; 2018 Oct; 17(10):3418-3430. PubMed ID: 30207155
[TBL] [Abstract][Full Text] [Related]
33. Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis.
Jankovska E; Lipcseyova D; Svrdlikova M; Pavelcova M; Kubala Havrdova E; Holada K; Petrak J
Int J Neurosci; 2022 Jul; 132(7):724-734. PubMed ID: 33059501
[TBL] [Abstract][Full Text] [Related]
34. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
35. Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.
Stoop MP; Coulier L; Rosenling T; Shi S; Smolinska AM; Buydens L; Ampt K; Stingl C; Dane A; Muilwijk B; Luitwieler RL; Sillevis Smitt PA; Hintzen RQ; Bischoff R; Wijmenga SS; Hankemeier T; van Gool AJ; Luider TM
Mol Cell Proteomics; 2010 Sep; 9(9):2063-75. PubMed ID: 20811074
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review.
Wesenhagen KEJ; Teunissen CE; Visser PJ; Tijms BM
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):86-98. PubMed ID: 31694431
[TBL] [Abstract][Full Text] [Related]
37. A Targeted Proteomics Analysis of Cerebrospinal Fluid after Acute Human Spinal Cord Injury.
Streijger F; Skinnider MA; Rogalski JC; Balshaw R; Shannon CP; Prudova A; Belanger L; Ritchie L; Tsang A; Christie S; Parent S; Mac-Thiong JM; Bailey C; Urquhart J; Ailon T; Paquette S; Boyd M; Street J; Fisher CG; Dvorak MF; Borchers CH; Foster LJ; Kwon BK
J Neurotrauma; 2017 Jun; 34(12):2054-2068. PubMed ID: 28276985
[TBL] [Abstract][Full Text] [Related]
38. Identification of Central Nervous System Oncologic Disease Biomarkers in EVs from Cerebrospinal Fluid (CSF) of Pediatric Patients: A Pilot Neuro-Proteomic Study.
Kajana X; Spinelli S; Garbarino A; Balagura G; Bartolucci M; Petretto A; Pavanello M; Candiano G; Panfoli I; Bruschi M
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136601
[TBL] [Abstract][Full Text] [Related]
39. Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood.
Bruijstens AL; Stingl C; Güzel C; Stoop MP; Wong YYM; van Pelt ED; Banwell BL; Bar-Or A; Luider TM; Neuteboom RF;
Mult Scler; 2023 Jan; 29(1):52-62. PubMed ID: 36154753
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: A pilot study.
Priola GM; Foster MW; Deal AM; Richardson BM; Thompson JW; Blatt J
Pediatr Blood Cancer; 2015 Jul; 62(7):1190-4. PubMed ID: 25809122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
